Biogaia

Biogaia EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Biogaia (BIOG B.ST) as of Nov 16, 2026 is 25.69. In the previous year, EV/EBIT (Enterprise Value to EBIT) was 25.03 — a change of 2.64% (higher).

EV/EBIT

25.69

YoY

2.64%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Biogaia is 2025 25.69 . EV/EBIT (Enterprise Value to EBIT) of Biogaia was 2024 25.03 . It decreases by 2.64% higher compared to the previous year.

The Biogaia EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
43.70 SEK
Jan 1, 2020
46.45 SEK
Jan 1, 2021
41.77 SEK
Jan 1, 2022
29.32 SEK
Jan 1, 2023
23.92 SEK
Jan 1, 2024
25.03 SEK
Jan 1, 2025
25.69 SEK
Jan 1, 2026 (e)
24.52 SEK
The Biogaia EV/EBIT history
YEAREV/EBITYoY
est24.52-4.57%
25.69+2.64%
25.03+4.66%
23.92-18.43%
29.32-29.80%
41.77-10.08%
46.45+6.29%
43.70+14.37%
38.21-15.69%
45.32-14.71%
53.14-23.69%
69.64+29.37%
53.83+0.15%
53.75+661.33%
7.06-74.17%
27.33-7.26%
29.47+1.45%
29.05+31.81%
22.04-65.18%
63.29-86.74%
477.23—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biogaia Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Biogaia's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Biogaia's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Biogaia's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Biogaia grows earnings faster than its peers.

Biogaia Stock analysis

What does Biogaia do? BioGaia AB generates revenue through its probiotic product segments, primarily featuring Limosilactobacillus reuteri strains. The Paediatrics segment sells drops, gut health tablets, oral rehydration solutions, and cultures for licensee products. The Adult Health segment offers gut health tablets, oral health lozenges, and cultures integrated into dairy products by licensees. The Other segment includes royalties from development projects and revenue from CapAble's packaging solutions. Products are marketed globally to consumers seeking health benefits from probiotics, with licensees distributing branded items under agreements. The company targets health-conscious consumers through direct sales and licensed partnerships. Paediatrics products focus on infant and child health, while Adult Health products address digestive and oral wellness. CapAble, a subsidiary, contributes through packaging solutions, and royalties from development projects provide additional income streams. All segments operate under BioGaia's brand, leveraging documented health benefits of their probiotic strains. Biogaia is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biogaia stock

EV/EBIT (Enterprise Value to EBIT) of Biogaia is 25.69 in 2025.

EV/EBIT (Enterprise Value to EBIT) of Biogaia changed from 25.03 to 25.69, representing a 2.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Biogaia since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Biogaia with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Biogaia

All Key Metrics — Biogaia